39-desmethoxy derivatives of rapamycin
US8008318B2 · kind B2 · utility
6Cited by
33References
1Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 3, 2009 |
| Grant date | Aug 30, 2011 |
| Priority date | — |
| Expiry date | Dec 3, 2029 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P37/06
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to 39-desmethoxyrapamycin derivatives and their uses thereof. The present invention provides for the use of these compounds in the treatment of cancer and/or B-cell malignancies, the induction or maintenance of immunosuppression, the treatment of transplantation rejection, graft vs. host disease, autoimmune disorders, diseases of inflammation, vascular disease and fibrotic diseases, the stimulation of neuronal regeneration or the treatment of fungal infections.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.